67
Views
0
CrossRef citations to date
0
Altmetric
Patent Evaluations

5-Hydroxymethyl-oxazolidin-2-one antibacterials

Actelion Pharmaceuticals: WO2008062379

, PhD &
Pages 529-540 | Published online: 08 Apr 2009
 

Abstract

The application, WO2008062379, claims chimeric compounds comprising chemically linked 5-hydroxymethyl-oxazolidinone and tetracyclic-quinolone moieties. The claimed compounds are potent expanded-range antibacterial agents against selected Gram-positive and Gram-negative bacteria, which may exhibit dual mode of action as inhibitors of topoisomarases IV and protein synthesis. The structures of the compounds suggest that the linkers are chemically and biochemically stable. This application represents part of recently initiated research efforts at Actelion.

View correction statement:
Erratum

Acknowledgement

The authors would like to thank the Faculty of Pharmacy, Kuwait University for providing the facilities during the preparation of this manuscript.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.